Multimorbidity in South Africa: a systematic review of prevalence studies

Rifqah Abeeda Roomaney, Brian van Wyk, Eunice Bolanle Turawa, Victoria Pillay-van Wyk, Rifqah Abeeda Roomaney, Brian van Wyk, Eunice Bolanle Turawa, Victoria Pillay-van Wyk

Abstract

Objectives: To review prevalence studies of multimorbidity in South Africa to identify prevalence estimates, common disease clusters and factors associated with multimorbidity.

Design: Systematic review.

Setting: South Africa (general community and healthcare facilities).

Data sources: Articles were retrieved from electronic databases (PubMed, Web of Science, Scopus, CINAHL, Science Direct and JSTOR).

Eligibility criteria: Studies addressing the prevalence of multimorbidity in South Africa were eligible for inclusion. A systematic search was done in various databases up to December 2020. A risk of bias assessment was conducted for each article using a modified checklist.

Study selection: Two researchers independently screened titles and abstracts; assessed the risk of bias of each study and extracted data. Included studies were described using a narrative synthesis.

Results: In total, 1407 titles were retrieved; of which 10 articles were included in the narrative synthesis. Six studies had a low risk of bias and three had a moderate risk of bias. One study was not assessed for risk of bias, because there was no criteria that apply to routine health information systems. Three of the included studies were population-based surveys, four were community-based cohorts and three cross-sectional studies of health facility data. The prevalence of multimorbidity was low to moderate (3%-23%) in studies that included younger people or had a wide range of selected age groups; and moderate to high (30%-87%) in studies of older adults. The common disease clusters were hypertension and diabetes, hypertension and HIV, and TB and HIV.

Conclusion: All studies indicated that multimorbidity is a norm in South Africa, especially among older adults. Hypertension is the main driver of multimorbidity. Research on multimorbidity in South Africa needs to be strengthened with high-quality study designs.

Prospero registration number: CRD42020196895.

Keywords: epidemiology; public health.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
PRISMA flow diagram. PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses.
Figure 2
Figure 2
Graph of multimorbidity prevalence estimates for studies that include younger age groups.
Figure 3
Figure 3
Graph of multimorbidity prevalence in studies including persons aged 50 years and older.

References

    1. Nguyen H, Manolova G, Daskalopoulou C, et al. . Prevalence of multimorbidity in community settings: a systematic review and meta-analysis of observational studies. J Comorb 2019;9:2235042X1987093–15. 10.1177/2235042X19870934
    1. Xu X, Mishra GD, Jones M. Mapping the global research landscape and knowledge gaps on multimorbidity: a bibliometric study. J Glob Health 2017;7:010414. 10.7189/jogh.07.010414
    1. World Health Organization . Multimorbidity: technical series on safer primary care; report No.: 9241511656. Geneva: World Health Organization, 2016.
    1. Wei MY, Mukamal KJ, Multimorbidity MKJ. Multimorbidity, mortality, and long-term physical functioning in 3 prospective cohorts of community-dwelling adults. Am J Epidemiol 2018;187:103–12. 10.1093/aje/kwx198
    1. Kanesarajah J, Waller M, Whitty JA, et al. . Multimorbidity and quality of life at mid-life: a systematic review of general population studies. Maturitas 2018;109:53–62. 10.1016/j.maturitas.2017.12.004
    1. Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, et al. . Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract 2012;62:e821–6. 10.3399/bjgp12X659295
    1. Sum G, Salisbury C, Koh GC-H, et al. . Implications of multimorbidity patterns on health care utilisation and quality of life in middle-income countries: cross-sectional analysis. J Glob Health 2019;9:020413. 10.7189/jogh.09.020413
    1. Frølich A, Ghith N, Schiøtz M, et al. . Multimorbidity, healthcare utilization and socioeconomic status: a register-based study in Denmark. PLoS One 2019;14:e0214183. 10.1371/journal.pone.0214183
    1. Maddaloni E, D’Onofrio L, Alessandri F, et al. . Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II). Cardiovasc Diabetol 2020;19:1–11. 10.1186/s12933-020-01140-2
    1. Iaccarino G, Grassi G, Borghi C, et al. . Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of hypertension. Hypertension 2020;76:366–72. 10.1161/HYPERTENSIONAHA.120.15324
    1. The Lancet . Making more of multimorbidity: an emerging priority. Lancet 2018;391:1637. 10.1016/S0140-6736(18)30941-3
    1. The Academy of Medical Sciences . Multimorbidity: a priority for global health research 2018, 2020. Available:
    1. Simbayi L, Zuma K, Moyo S. South African national HIV prevalence, incidence, behaviour and communication survey, 2017; report No.: 978-0-7969-2444-5. Cape Town: HSRC Press, 2019.
    1. Chang AY, Gómez-Olivé FX, Manne-Goehler J, et al. . Multimorbidity and care for hypertension, diabetes and HIV among older adults in rural South Africa. Bull World Health Organ 2019;97:10–23. 10.2471/BLT.18.217000
    1. Nojilana B, Bradshaw D, Pillay-van Wyk V, et al. . Emerging trends in non-communicable disease mortality in South Africa, 1997 - 2010. S Afr Med J 2016;106:477–84. 10.7196/SAMJ.2016.v106i5.10674
    1. Mudie K, Jin MM, Kendall L, et al. . Non-Communicable diseases in sub-Saharan Africa: a scoping review of large cohort studies. J Glob Health 2019;9:020409. 10.7189/jogh.09.020409
    1. Oni T, McGrath N, BeLue R, et al. . Chronic diseases and multi-morbidity-a conceptual modification to the WHO ICCC model for countries in health transition. BMC Public Health 2014;14:575. 10.1186/1471-2458-14-575
    1. Mahomed OH, Asmall S. Professional nurses' perceptions and experiences with the implementation of an integrated chronic care model at primary healthcare clinics in South Africa. Curationis 2017;40:1–6. 10.4102/curationis.v40i1.1708
    1. Mahomed OH, Asmall S. Development and implementation of an integrated chronic disease model in South Africa: lessons in the management of change through improving the quality of clinical practice. Int J Integr Care 2015;15:e038. 10.5334/ijic.1454
    1. Limbani F, Thorogood M, Gómez-Olivé FX, et al. . Task shifting to improve the provision of integrated chronic care: realist evaluation of a lay health worker intervention in rural South Africa. BMJ Glob Health 2019;4:e001084. 10.1136/bmjgh-2018-001084
    1. Ameh S, Klipstein-Grobusch K, D'ambruoso L, et al. . Quality of integrated chronic disease care in rural South Africa: user and provider perspectives. Health Policy Plan 2017;32:257–66. 10.1093/heapol/czw118
    1. Fortin M, Stewart M, Poitras M-E, et al. . A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med 2012;10:142–51. 10.1370/afm.1337
    1. Roomaney RA, van Wyk B, Turawa EB, et al. . Prevalence of multimorbidity in South Africa: a systematic review protocol. BMJ Open 2020;10:e042889. 10.1136/bmjopen-2020-042889
    1. Moher D, Liberati A, Tetzlaff J, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. 10.1371/journal.pmed.1000097
    1. The EndNote Team . Endnote. EndNote X8 ed. Philadelphia, PA: Clarivate, 2013.
    1. Ouzzani M, Hammady H, Fedorowicz Z, et al. . Rayyan-a web and mobile APP for systematic reviews. Syst Rev 2016;5:210. 10.1186/s13643-016-0384-4
    1. Roomaney RA, Awotiwon OF. Burden of disease review manager for systematic review of observational studies: technical report version 1. Cape Town: South African Medical Research Council, 2017.
    1. Wells GA, Tugwell P, O’Connell D, et al. . The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses, 2015. Available:
    1. Hoy D, Brooks P, Woolf A, et al. . Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 2012;65:934–9. 10.1016/j.jclinepi.2011.11.014
    1. Pheiffer C, Pillay-van Wyk V, Joubert JD, et al. . The prevalence of type 2 diabetes in South Africa: a systematic review protocol. BMJ Open 2018;8:e021029. 10.1136/bmjopen-2017-021029
    1. Rohatgi A. WebPlotDigitizer version: 4.3 2020.
    1. Afshar S, Roderick PJ, Kowal P, et al. . Multimorbidity and the inequalities of global ageing: a cross-sectional study of 28 countries using the world health surveys. BMC Public Health 2015;15:776. 10.1186/s12889-015-2008-7
    1. Garin N, Koyanagi A, Chatterji S, et al. . Global multimorbidity patterns: a cross-sectional, population-based, Multi-Country study. J Gerontol A Biol Sci Med Sci 2016;71:205–14. 10.1093/gerona/glv128
    1. Weimann A, Dai D, Oni T. A cross-sectional and spatial analysis of the prevalence of multimorbidity and its association with socioeconomic disadvantage in South Africa: a comparison between 2008 and 2012. Soc Sci Med 2016;163:144–56. 10.1016/j.socscimed.2016.06.055
    1. Ghose B, Abdoul Razak MY. Memory and learning complaints in relation to depression among elderly people with multimorbidity. Geriatrics 2017;2. 10.3390/geriatrics2020015. [Epub ahead of print: 09 May 2017].
    1. van Heerden A, Barnabas RV, Norris SA, et al. . High prevalence of HIV and non-communicable disease (Ncd) risk factors in rural KwaZulu-Natal, South Africa. J Int AIDS Soc 2017;20:e25012. 10.1002/jia2.25012
    1. Chang AY, Gómez-Olivé FX, Payne C, et al. . Chronic multimorbidity among older adults in rural South Africa. BMJ Glob Health 2019;4:e001386. 10.1136/bmjgh-2018-001386
    1. Sharman M, Bachmann M. Prevalence and health effects of communicable and non-communicable disease comorbidity in rural KwaZulu-Natal, South Africa. Trop Med Int Health 2019;24:1198–207. 10.1111/tmi.13297
    1. Lalkhen H, Mash R. Multimorbidity in non-communicable diseases in South African primary healthcare. S Afr Med J 2015;105:134–8. 10.7196/SAMJ.8696
    1. Roche S, De Vries E. Multimorbidity in a large district Hospital: a descriptive cross-sectional study. S Afr Med J 2017;107:1110–5. 10.7196/SAMJ.2017.v107i12.12397
    1. Oni T, Youngblood E, Boulle A, et al. . Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study. BMC Infect Dis 2015;15:20. 10.1186/s12879-015-0750-1
    1. Weimann A, Dai D, Oni T. A cross-sectional and spatial analysis of the prevalence of multimorbidity and its association with socioeconomic disadvantage in South Africa: a comparison between 2008 and 2012. Soc Sci Med 2016;163:144–56. 10.1016/j.socscimed.2016.06.055
    1. Alaba O, Chola L. The social determinants of multimorbidity in South Africa. Int J Equity Health 2013;12:1. 10.1186/1475-9276-12-63
    1. Griffith LE, Gruneir A, Fisher KA, et al. . Key factors to consider when measuring multimorbidity: results from an expert panel and online survey. J Comorb 2018;8:2235042x18795306. 10.1177/2235042X18795306
    1. National Department of Health, Statistics South Africa, South African Medical Research Council, and ICF . South Africa demographic and health survey 2016. Pretoria, South Africa, and Rockville, Maryland, USA: NDoH, Stats SA, SAMRC, and ICF, 2019.
    1. Pillay-van Wyk V, Bradshaw D, Groenewald P, et al. . COVID deaths in South Africa: 99 days since South Africa's first death. S Afr Med J 2020;110:1093–9.
    1. South African Medical Research Council, Department of Science and Innovation . South African population research infrastructure network launches two new urban nodes to expand to a nationwide network and improve response to COVID-19 and other epidemics, 2020. Available:
    1. Mannie C, Kharrazi H. Assessing the geographical distribution of comorbidity among commercially insured individuals in South Africa. BMC Public Health 2020;20:1709. 10.1186/s12889-020-09771-6
    1. Sum G, Hone T, Atun R, et al. . Multimorbidity and out-of-pocket expenditure on medicines: a systematic review. BMJ Glob Health 2018;3:e000505. 10.1136/bmjgh-2017-000505
    1. Pati S, Swain S, Hussain MA, et al. . Prevalence and outcomes of multimorbidity in South Asia: a systematic review. BMJ Open 2015;5:e007235. 10.1136/bmjopen-2014-007235
    1. Academy of Science of South Africa . Improving the prevention and management of multimorbidity in sub-Saharan Africa, 2020. Available:

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner